Cargando…

Economic evaluation of highly purified human menotropin or recombinant follicle-stimulating hormone for controlled ovarian stimulation in high-responder patients: analysis of the Menopur in Gonadotropin-releasing Hormone Antagonist Single Embryo Transfer–High Responder (MEGASET-HR) trial

OBJECTIVE: To determine the cost of achieving a live birth after first transfer using highly purified human menotropin (HP-hMG) or recombinant follicle-stimulating hormone (FSH) for controlled ovarian stimulation in predicted high-responder patients in the Menopur in Gonadotropin-releasing hormone A...

Descripción completa

Detalles Bibliográficos
Autores principales:	Robins, Jared C., Khair, Andrew F., Widra, Eric A., Alper, Michael M., Nelson, Winnie W., Foster, Eric D., Sinha, Anshul, Ando, Masakazu, Heiser, Patrick W., Daftary, Gaurang S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8244378/ https://www.ncbi.nlm.nih.gov/pubmed/34223253 http://dx.doi.org/10.1016/j.xfre.2020.09.010

Ejemplares similares

Highly Purified Human Menopausal Gonadotropin (HP-hMG) Versus Recombinant Follicle-Stimulating Hormone (rFSH) for Controlled Ovarian Stimulation in US Predicted High-Responder Patients: A Cost-Comparison Analysis
por: Khair, Andrew, et al.
Publicado: (2023)

A comparison of menotropin, highly-purified menotropin and follitropin alfa in cycles of intracytoplasmic sperm injection
por: Esteves, Sandro C, et al.
Publicado: (2009)

Hormonal profile in early luteal phase after triggering ovulation with gonadotropin-releasing hormone agonist in high-responder patients
por: Martazanova, Bella, et al.
Publicado: (2022)

Dual trigger with gonadotropin-releasing hormone and human chorionic gonadotropin for poor responders
por: Eser, Ahmet, et al.
Publicado: (2018)

Original delayed-start ovarian stimulation protocol with a gonadotropin-releasing hormone antagonist, medroxyprogesterone acetate, and high-dose gonadotropin for poor responders and patients with poor-quality embryos
por: Takeuchi, Kazuhiro, et al.
Publicado: (2023)

Dual Trigger with Gonadotropin Releasing Hormone Agonist and Human Chorionic Gonadotropin of Fresh Autologous Cycles in High Responders: A Systematic Review
por: Vyrides, Andreas A, et al.
Publicado: (2022)

Endocrine profile following stimulation with recombinant follicle stimulating hormone and luteinizing hormone versus highly purified human menopausal gonadotropin
por: Requena, Antonio, et al.
Publicado: (2014)

Corifollitropin α followed by menotropin for poor ovarian responders’ trial (COMPORT): a protocol of a multicentre randomised trial
por: Polyzos, Nikolaos P, et al.
Publicado: (2013)

Gonadotropin-releasing hormone agonist triggering with concomitant administration of low doses of human chorionic gonadotropin or a freeze-all strategy in high responders
por: Karacan, Meric, et al.
Publicado: (2017)

Follicle Stimulating Hormone and Anti-Müllerian Hormone per Oocyte in Predicting in vitro Fertilization Pregnancy in High Responders: A Cohort Study
por: Weghofer, Andrea, et al.
Publicado: (2012)

A Case of Cyclic Vomiting Syndrome Responding to Gonadotropin-Releasing Hormone Analogue
por: Shin, Young Kook, et al.
Publicado: (2010)

Fresh versus frozen embryo transfer after gonadotropin-releasing hormone agonist trigger in gonadotropin-releasing hormone antagonist cycles among high responder women: A randomized, multi-center study
por: Aflatoonian, Abbas, et al.
Publicado: (2018)

Medroxyprogesterone Acetate versus Gonadotropin-Releasing Hormone Antagonist for the Prevention of Premature Luteinizing Hormone Surge in hyper-responder women undergoing controlled ovarian stimulation for IVF/ICSI Cycles
por: Tandulwadkar, Sunita, et al.
Publicado: (2023)

Cumulative Live Birth Rate and Cost-Effectiveness Analysis of Gonadotropin Releasing Hormone-Antagonist Protocol and Multiple Minimal Ovarian Stimulation in Poor Responders
por: Liu, Yuan, et al.
Publicado: (2021)

The earlier the initiation of gonadotropin in poor responders in luteal phase stimulation protocols, the better
por: Huang, Jia, et al.
Publicado: (2022)

Gonadotropin-releasing Hormone Stimulation Test for Precocious Puberty
por: Kim, Han Kyul, et al.
Publicado: (2011)

First pre-filled pen device with highly purified human menopausal gonadotropin (HP-hMG, Menopur) in liquid is shown to be bioequivalent to powder for reconstitution
por: Jonker, Daniël M., et al.
Publicado: (2021)

Analysis of Nurse and Patient Preferences for Pre-Filled Pen Devices for Self-Injection of Highly Purified Human Menopausal Gonadotropin (HP-hMG, MENOPUR(®))
por: De Mesmaeker, Guy, et al.
Publicado: (2023)

Gonadotropin releasing hormone analogs as part of controlled ovarian stimulation
por: Fleming, Richard
Publicado: (2022)

Luteinizing hormone-like and follicle-stimulating hormone-like activities of equine chorionic gonadotropin β-subunit mutants in cells expressing rat luteinizing hormone/chorionic gonadotropin receptor and rat follicle-stimulating hormone receptor
por: Byambaragchaa, Munkhzaya, et al.
Publicado: (2021)

Different gonadotropin releasing hormone agonist doses for the final oocyte maturation in high-responder patients undergoing in vitro fertilization/intra-cytoplasmic sperm injection
por: Pabuccu, Emre Goksan, et al.
Publicado: (2015)

The enigma of the gonadotropin-releasing hormone pulse frequency governing individual secretion of luteinizing hormone and follicle-stimulating hormone
por: Lambalk, Cornelis B.
Publicado: (2023)

Clinical Outcomes of Frozen-Thawed Embryos Generated From Growth Hormone Stimulation in Expected Poor Responders
por: Zhu, Jinliang, et al.
Publicado: (2021)

SAT-420 Gonadotropin-Releasing Hormone Stimulates Luteinizing Hormone Exocytosis without Elevating Lhb Expression
por: Janjic, Marija, et al.
Publicado: (2019)

Impact of gonadotropin-releasing hormone antagonist addition on pregnancy rates in gonadotropin-stimulated intrauterine insemination cycles
por: Jain, Shikha, et al.
Publicado: (2016)

Dual trigger with gonadotropin-releasing hormone agonist and human chorionic gonadotropin significantly improves oocyte yield in normal responders on GnRH-antagonist cycles
por: Albeitawi, Soha, et al.
Publicado: (2022)

A Comparison of Outcomes from In Vitro Fertilization Cycles Stimulated with Follicle Stimulating Hormone Plus either Recombinant Luteinizing Hormone or Human Menopausal Gonadotropins in Subjects Treated with Long Gonadotropin Releasing Hormone Agonist Protocols
por: Bleau, Nathalie, et al.
Publicado: (2017)

Luteal Support with very Low Daily Dose of Human Chorionic Gonadotropin after Fresh Embryo Transfer as an Alternative to Cycle Segmentation for High Responders Patients Undergoing Gonadotropin-Releasing Hormone Agonist-Triggered IVF
por: Carosso, Andrea Roberto, et al.
Publicado: (2021)

Reimann's “Habitual Hyperthermia” Responding to Hormone Therapy
por: Yang, Otto O., et al.
Publicado: (2016)

Consecutive versus concomitant follicle-stimulating hormone and highly purified human menopausal gonadotropin: A milder response but better quality
por: Maghraby, Hassan Ali, et al.
Publicado: (2022)

Time Points for Gonadotropin-Releasing Hormone Stimulation Test Results in Korean Children
por: Choi, Rihwa, et al.
Publicado: (2021)

"High normal" thyroid stimulating hormone: does it matter?
por: Chun, Hyunji, et al.
Publicado: (2013)

Luteinizing Hormone Secretion during Gonadotropin-Releasing Hormone Stimulation Tests in Obese Girls with Central Precocious Puberty
por: Lee, Hae Sang, et al.
Publicado: (2016)

Role of Gonadotropin-releasing Hormone Stimulation Test in Diagnosing Gonadotropin Deficiency in Both Males and Females with Delayed Puberty
por: Sun, Qi-Hong, et al.
Publicado: (2015)

Low Dose Growth Hormone Adjuvant Treatment With Ultra-Long Ovarian Stimulation Protocol in Poor Responders Showed Non-inferior Pregnancy Outcome Compared With Normal Responders
por: Lee, Yi-Xuan, et al.
Publicado: (2019)

Ovarian stimulation modalities in poor responders
por: ÖZKAN, Zehra Sema
Publicado: (2019)

Effects of letrozole co-treatment on the cumulative live-birth rate among normal responders in gonadotropin-releasing hormone antagonist cycles
por: Zhang, Shuyi, et al.
Publicado: (2022)

Progestin vs. Gonadotropin-Releasing Hormone Antagonist for the Prevention of Premature Luteinizing Hormone Surges in Poor Responders Undergoing in vitro Fertilization Treatment: A Randomized Controlled Trial
por: Chen, Qiuju, et al.
Publicado: (2019)

Subcutaneously administered Menopur(R), a new highly purified human menopausal gonadotropin, causes significantly fewer injection site reactions than Repronex(R) in subjects undergoing in vitro fertilization
por: Keye, William R, et al.
Publicado: (2005)

Comparison of corifollitropin alfa and daily recombinant follicle-stimulating hormone in poor responder patients undergoing in vitro fertilization cycles
por: Akarsu, Süleyman, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_vrc6r71noprvuil14hj7l8hvtg